Lipid Lowering Therapy in the Elderly: Is there a Benefit?
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3945-3960
Author(s):
Kallirroi J. Kalantzi, Haralampos J. Milionis, Dimitri P. Mikhailidis and John A. Goudevenos
Editorial [ The Metabolic Syndrome: Revisiting the Concept, the Diagnosis and the Treatment (Part-II) Guest Editors: John H. McNeill and Vijay Sharma ]
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
291-291
Author(s):
The Etiology of Hypertension in the Metabolic Syndrome Part One: An Introduction to the History, the Concept and the Models
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
293-304
Author(s):
The Etiology of Hypertension in the Metabolic Syndrome Part Two: The Gene-Environment Interaction
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
305-320
Author(s):
The Etiology of Hypertension in the Metabolic Syndrome Part Three: The Regulation and Dysregulation of Blood Pressure
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
321-348
Author(s):
The Etiology of Hypertension in the Metabolic Syndrome Part Four: The Systemic Perspective – The Role of the Neuroendocrine and Immune Systems,and the Challenge of Integration
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
349-381
Author(s):
Leptin and Vascular Smooth Muscle
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
383-393
Author(s):
Recent Insights into the Role of Prostanoids in Atherosclerotic Vascular Disease
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
395-408
Author(s):
Lipid Modulation of Intravascular and Cellular Sodium Handling:Mechanistic Insights and Potential Clinical Implications
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
409-416
Author(s):
Intracellular Amyloid β-Protein and Its Associated Molecules in the Pathogenesis of Alzheimers Disease
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
6
Page:
1075-1080
Author(s):
Yasumasa Ohyagi and Takeshi Tabira